UTM.F UTAH MED. PRODS DL-01
- Market cap
- EUR 186M
- P/E
- 22.8x
- P/B
- 1.66x
- ROE
- 8.7%
- Dividend yield
- 1.75%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is UTM.F undervalued?
Graham numberUTM.F trades 29.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
UTAH MED. PRODS DL-01 fundamental analysis
No fundamental analysis for UTAH MED. PRODS DL-01 yet.
UTAH MED. PRODS DL-01 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About UTAH MED. PRODS DL-01
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protecti…
Full company profileUTAH MED. PRODS DL-01 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
UTAH MED. PRODS DL-01 annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 49.1M | 52.3M | 50.2M | 40.9M | 38.5M | 34.5M |
| Gross Profit | 30.9M | 32.2M | 30.0M | 24.1M | 22.0M | 20.1M |
| Operating Income | 18.9M | 19.8M | 16.8M | 13.6M | 11.4M | 11.3M |
| EBITDA | - | 26.9M | 23.1M | 16.4M | 14.4M | 13.2M |
| Net Income | 14.8M | 16.5M | 16.6M | 13.9M | 11.3M | 10.6M |
| EPS | 4.05 | 4.54 | 4.58 | 4.16 | 3.54 | 3.32 |
| Balance Sheet | ||||||
| Total Assets | 116M | 124M | 135M | 123M | 123M | 125M |
| Total Liabilities | 8.50M | 9.62M | 7.15M | 5.11M | 3.27M | 2.54M |
| Shareholders' Equity | 107M | 114M | 128M | 117M | 119M | 122M |
| Cash & Short-term Investments | 61.0M | 75.1M | 92.9M | 83.0M | 85.8M | 87.5M |
| Cash Flow | ||||||
| Operating Cash Flow | 21.2M | 21.1M | 22.3M | 14.8M | 14.7M | 8.98M |
| Capital Expenditure | 552K | 818K | 639K | 235K | 371K | 528K |
| Free Cash Flow | 20.7M | 20.3M | 21.6M | 14.6M | 14.3M | 8.46M |
| Ratios | ||||||
| ROE | 13.8% | 14.4% | 13.0% | 11.8% | 9.5% | 8.7% |
| ROA | 12.8% | 13.3% | 12.3% | 11.3% | 9.2% | 8.5% |
| Net Profit Margin | 30.1% | 31.5% | 33.1% | 33.9% | 29.3% | 30.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
UTAH MED. PRODS DL-01 dividends
- Dividend yield
- 1.75%
- Forward dividend
- 1.12 EUR
- Payout ratio
- 35.3%
- Ex-dividend date
- Dec 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 3.98M | 1.25 | 35.3% |
| 2024 | USD 4.26M | 1.28 | 30.7% |
| 2023 | USD 4.28M | 1.18 | 25.7% |
| 2022 | USD 3.16M | 0.87 | 19.2% |
| 2021 | USD 11.5M | 3.14 | 77.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns UTAH MED. PRODS DL-01
- Insiders 7.20%
- Institutions 75.85%
- Public & others 16.96%
- Shares outstanding 2.85M
- Free float 2.77M
UTAH MED. PRODS DL-01 company profile
- Company name
- UTAH MED. PRODS DL-01
- Ticker
- UTM.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 140
- Fiscal year end
- December
- Address
- 7043 South 300 West, Midvale, UT, United States, 84047-1048
- Phone
- 801 566 1200
- Website
- utahmed.com
About UTAH MED. PRODS DL-01
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
UTAH MED. PRODS DL-01 management
4- Mr. Kevin L. CornwellChairman, CEO, President & Secretary · born 1947
- Mr. Brian L. KoopmanPrincipal Financial Officer, Accounting Manager & Controller · born 1970
- Mark L. FoxVice President of Marketing
- Marcena H. ClawsonVice President of Corporate Sales